Page last updated: 2024-08-22

ozone and ifosfamide

ozone has been researched along with ifosfamide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Hohorst, HJ; Peter, G; Struck, RF1
Hong, PK; Hsueh, JH; Lin, AY1
Blaney, L; Katz, LE; Lawler, DF1
Akira, K; Funahashi, T; Hakuba, Y; Hasebe, M; Hatae, N; Hidaka, N; Kato, G; Koike, Y; Mitome, H; Tanabe, T; Tanaka, M; Tawa, K; Teshima, K1

Other Studies

4 other study(ies) available for ozone and ifosfamide

ArticleYear
Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
    Cancer research, 1976, Volume: 36, Issue:7 PT 1

    Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cyclophosphamide; Drug Evaluation, Preclinical; Ifosfamide; Leukemia L1210; Ozone

1976
Removal of antineoplastic drugs cyclophosphamide, ifosfamide, and 5-fluorouracil and a vasodilator drug pentoxifylline from wastewaters by ozonation.
    Environmental science and pollution research international, 2015, Volume: 22, Issue:1

    Topics: Aliivibrio fischeri; Antineoplastic Agents; Cyclophosphamide; Fluorouracil; Hydroxyl Radical; Ifosfamide; Ozone; Pentoxifylline; Toxicity Tests; Vasodilator Agents; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Pollution, Chemical

2015
Transformation kinetics of cyclophosphamide and ifosfamide by ozone and hydroxyl radicals using continuous oxidant addition reactors.
    Journal of hazardous materials, 2019, 02-15, Volume: 364

    Topics: Antineoplastic Agents; Cyclophosphamide; Hydroxyl Radical; Ifosfamide; Kinetics; Oxidants; Ozone; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification

2019
Study on the Use of Ozone Water as a Chemical Decontamination Agent for Antineoplastic Drugs in Clinical Settings.
    Annals of work exposures and health, 2023, 02-13, Volume: 67, Issue:2

    Topics: Antineoplastic Agents; Cisplatin; Cyclophosphamide; Decontamination; Doxorubicin; Fluorouracil; Humans; Ifosfamide; Mutagens; Occupational Exposure; Oxaliplatin; Ozone; Pemetrexed; Water

2023